Randall J. Lewis - 05 May 2026 Form 4 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 May 2026, 16:20:03 UTC
Prior SEC filing
01 Apr 2026
Next SEC filing
15 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Towns, Attorney-in-Fact

Key filing fact

Randall J. Lewis filed Form 4 for Guardian Pharmacy Services, Inc. (GRDN) on 07 May 2026.

Key facts

  • This page summarizes Randall J. Lewis's Form 4 filing for Guardian Pharmacy Services, Inc. (GRDN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 May 2026, 16:20.

Change

  • Previous filing in this sequence was filed on 01 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001123485 Primary reporting owner

LEWIS RANDALL J

Relationship
Director
Address
300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA
Signature
/s/ Douglas Towns, Attorney-in-Fact
Signature date
07 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GRDN transaction

Class A Common Stock

Award

Transaction value
Shares
+4,028
Change %
+36%
Price
$0.000000*
Shares after
15,071
Date
05 May 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units payable solely in shares of Class A common stock of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .